Skip to main navigation Skip to search Skip to main content

Bevacizumab-Induced Thrombotic Microangiopathy (TMA) in Metastatic Lung Adenocarcinoma Patients Receiving Nivolumab Combined with Bevacizumab, Carboplatin and Paclitaxel: Two Case Reports

  • Ping Chih Hsu
  • , Tai Di Chen
  • , Tsung Yu Tsai
  • , Cheng Ta Yang*
    • *Corresponding author for this work
  • Chang Gung University
  • Chang Gung Memorial Hospital

Research output: Contribution to journal › Journal Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Bevacizumab-Induced Thrombotic Microangiopathy (TMA) in Metastatic Lung Adenocarcinoma Patients Receiving Nivolumab Combined with Bevacizumab, Carboplatin and Paclitaxel: Two Case Reports'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science